Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study

Chern, CU; Tsui, KH; Vitale, SG; Chen, SN; Wang, PH; Cianci, A; Tsai, HW; Wen, ZH; Lin, LT

Lin, LT (reprint author), Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, 386 Dazhong 1st Rd, Kaohsiung 81362, Taiwan.; Lin, LT (reprint author), Natl Yang Ming Univ, Dept Obstet & Gynecol, Sch Med, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2018; 16 ():

Abstract

Background: Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian responders (PORs).......

Full Text Link